NCT03519178 2025-11-14A Study of PF-06873600 in People With CancerPfizerPhase 1/2 Terminated155 enrolled 44 charts
NCT02751528 2025-01-13QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast CancerNantBioScience, Inc.Phase 1 Terminated3 enrolled 10 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00006370 2013-05-01Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast CancerNovartisPhase 2 Completed275 enrolled
NCT00106002 2009-06-01Pemetrexed as the First Treatment in Advanced or Metastatic Breast CancerEli Lilly and CompanyPhase 2 Completed37 enrolled 9 charts